A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2027 in Healthy Subjects
Completed · Phase 1 · Has a placebo group
Conditions studied: Healthy Subjects
In brief
The purpose of this study is to evaluate the safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of multiple ascending oral doses of E2027 in healthy participants.
Key facts
- Study ID
- NCT02873156
- Run by
- Eisai Inc.
- People needed
- 74
- Starts
- 2016-08-10
- Expected to finish
- 2017-11-29
- Last updated by the study team
- 2018-09-07
Who can join
Age: 50 and older, up to 85. Sex: any. Healthy volunteers: accepted.
Where it is running
- California Clinical Trials Medical Group — Glendale, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.